脂肪便 (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "脂肪便" in Japanese language version.

refsWebsite

Global rank Japanese rank

low place

34^th place

255^th place

117^th place

47^th place

low place

cspinet.org

“Frito-Lay Study: Olestra Causes "Anal Oil Leakage"”. Center for Science in the Public Interest. (February 13, 1997) 2007年7月7日閲覧. "The Frito-Lay report states: "The anal oil leakage symptoms were observed in this study (3 to 9% incidence range above background), as well as other changes in elimination. ... Underwear spotting was statistically significant in one of two low level consumer groups at a 5% incidence above background." Despite those problems, the authors of the report concluded that olestra-containing snacks "should have a high potential for acceptance in the marketplace.""
“Reported medical side-effects of Olestra according to Procter and Gamble studies”. Center for Science in the Public Interest 2007年6月21日閲覧. "Olestra sometimes causes underwear staining associated with "anal leakage." Olestra sometimes causes underwear staining. That phenomenon may be caused most commonly by greasy, hard-to-wipe-off fecal matter, but occasionally also from anal leakage (leakage of liquid olestra through the anal sphincter)."

“The Word Is 'Leakage'. Accidents may happen with a new OTC diet drug.”. Newsweek. (June 25, 2007) 2007年6月21日閲覧. "GlaxoSmithKline has a tip for people who decide to try Alli, the over-the-counter weight-loss drug it is launching with a multimillion-dollar advertising blitz—keep an extra pair of pants handy. That's because Alli, a lower-dose version of the prescription drug Xenical, could (cue the late-night talk-show hosts) make you soil your pants. But while Alli's most troublesome side effect, anal leakage, is sure to be good for a few laughs, millions of people who are desperate to take off weight may still decide the threat of an accident is worth it."

Squires, Sally (2006年1月24日). “Weighing a Pill For Weight Loss”. Washington Post 2007年7月6日閲覧. "While the Food and Drug Administration (FDA) still must approve the switch, the agency often follows the advice of its experts. If it does, Orlistat (xenical) -- currently sold only by prescription -- could be available over-the-counter (OTC) later this year. But it's important to know that the weight loss that's typical for users of the drug -- 5 to 10 percent of total weight -- will be less than many dieters expect. And many consumers may be put off by the drug's significant gastrointestinal side effects, including flatulence, diarrhea and anal leakage."